Invacare Corp IVC
We take great care to ensure that the data presented and summarized in this overview for INVACARE CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding IVC
View all-
Rutabaga Capital Management LLC1.13MShares$22,5560.77% of portfolio
-
North Run Capital, LP Wellesley, MA444KShares$8,8740.43% of portfolio
-
Corbenic Partners LLC2KShares$400.0% of portfolio
-
Huntington National Bank Columbus, OH1Shares$00.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
Latest Institutional Activity in IVC
Top Purchases
Top Sells
About IVC
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products under the Invacare brand, as well as custom molded seat modules under the PinDot brand. It also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe patient handling products under the Birdie, Evo, and ISA brands; residential and institutional care beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Platinum and Perfecto2 brands; portable oxygen concentrators under the Platinum brand; and Invacare HomeFill oxygen systems. Further, it provides repair, equipment rentals, and external contracting services, as well as distributes heart rate monitors, thermometers, and nebulizers; and portable ramps. The company sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, dealers, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.
Insider Transactions at IVC
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 29
2024
|
Davidson Kempner Capital Management LP > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
472,865
+50.0%
|
-
|
Oct 29
2024
|
Endurant Capital Management LP |
BUY
Open market or private purchase
|
Indirect |
2,431,075
+50.0%
|
-
|
Oct 29
2024
|
Silverback Asset Management LLC |
BUY
Open market or private purchase
|
Indirect |
912,980
+50.0%
|
-
|
Oct 29
2024
|
Dg Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect |
1,408,002
+50.0%
|
-
|
Oct 29
2024
|
Tenor Capital Management Co., L.P. |
BUY
Open market or private purchase
|
Indirect |
713,698
+50.0%
|
-
|
Mar 13
2024
|
Silverback Asset Management LLC |
BUY
Other acquisition or disposition
|
Indirect |
2,705,409
+40.03%
|
-
|
Mar 13
2024
|
Dg Capital Management, LLC |
BUY
Other acquisition or disposition
|
Indirect |
4,182,724
+39.83%
|
-
|
Mar 13
2024
|
Tenor Capital Management Co., L.P. |
BUY
Other acquisition or disposition
|
Indirect |
2,114,876
+40.03%
|
-
|
Mar 13
2024
|
Davidson Kempner Capital Management LP > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
1,404,736
+39.83%
|
-
|
Nov 01
2023
|
Cintia Ferreira Sr. VP & CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
84,000
+50.0%
|
-
|
Nov 01
2023
|
Anthony La Placa Sr. VP, GC, CAO & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
140,000
+50.0%
|
-
|
Nov 01
2023
|
Geoffrey Purtill President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,204,000
+50.0%
|
-
|
Nov 01
2023
|
Randel G Owen Director |
BUY
Grant, award, or other acquisition
|
Direct |
66,860
+50.0%
|
-
|
Nov 01
2023
|
Peter J. Kuipers Director |
BUY
Grant, award, or other acquisition
|
Direct |
66,860
+50.0%
|
-
|
Nov 01
2023
|
Kai Zhu Sr. VP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
252,000
+50.0%
|
-
|
Nov 01
2023
|
Abraham T Han Director |
BUY
Grant, award, or other acquisition
|
Direct |
66,860
+50.0%
|
-
|
Nov 01
2023
|
Marec Elden Edgar Director |
BUY
Grant, award, or other acquisition
|
Direct |
66,860
+50.0%
|
-
|
Nov 01
2023
|
Kimberly Herman Director |
BUY
Grant, award, or other acquisition
|
Direct |
66,860
+50.0%
|
-
|
Nov 01
2023
|
Steven H Rosen |
BUY
Grant, award, or other acquisition
|
Direct |
87,209
+50.0%
|
-
|
May 05
2023
|
Azurite Management LLC |
SELL
Other acquisition or disposition
|
Direct |
3,665,233
-100.0%
|
-
|
Last 12 Months Summary
Other acquisition or disposition | 10.9M shares |
---|---|
Open market or private purchase | 5.47M shares |